To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Genzyme gets an OK for Framingham facility

By Chris Reidy

 |  Globe Staff  

  January 18, 2012

Genzyme Corp., the Cambridge unit of French drug maker Sanofi SA, said that European regulators have approved its manufacturing plant in Framingham for the production of Fabrazyme, a treatment for Fabry disease. Genzyme’s drug shipments have been hobbled for the past two years as the company recovers from a 2009 viral contamination of equipment at its Allston Landing plant. In December, Genzyme indicated that it is on track to resume full Fabrazyme deliveries in the second half of 2012.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help